feed,title,long_url,short_url
Benzinga,Centre Piece Of Merck's $11.5B Acceleron Buyout Aces Late-Stage Cardiovascular Trial,https://benzinga.com/general/biotech/22/10/29202221/centre-piece-of-mercks-11-5b-acceleron-buyout-aces-late-stage-cardiovascular-trial,https://bit.ly/3VdYmvv
Benzinga,Not Even The Post Office Is Immune To Inflation. Get The Forever Stamp Before It's Too Late.,https://benzinga.com/news/22/10/29203495/not-even-the-post-office-is-immune-to-inflation-get-the-forever-stamp-before-its-too-late,https://bit.ly/3MiIljZ
Benzinga,3 REITs With Dividends Above 8%,https://benzinga.com/real-estate/reit/22/10/29203656/3-reits-with-dividends-above-8,https://bit.ly/3RQKDbc
